Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients

Modern Pathology

Volumn 17, Issue 4, 2004, Pages 389-394

  Sun, Xiaoping ^a,b   Peterson, LoAnn C ^a   Gong, Yun ^a,b   Traynor, Ann E ^a,c   Nelson, Beverly P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Myeloma; PTLD; Solid organ transplantation

Indexed keywords

CYCLOSPORIN; DEXAMETHASONE; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLASMA PROTEIN; RNA; TACROLIMUS; EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 1; VIRUS RNA;

ADULT; AGED; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; INTESTINE GRAFT; KIDNEY GRAFT REJECTION; LIVER GRAFT REJECTION; LYMPHOPROLIFERATIVE DISEASE; MALE; MORTALITY; MULTIPLE MYELOMA; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECIPIENT; FATALITY; GENETICS; IMMUNE DEFICIENCY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; PARAPROTEINEMIA; PATHOLOGY; REVIEW;

AGED; FATAL OUTCOME; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MULTIPLE MYELOMA; ORGAN TRANSPLANTATION; PARAPROTEINEMIAS; POSTOPERATIVE COMPLICATIONS; RNA, VIRAL;

EID: 4644225237     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800080     Document Type: Article

References (40)

1. Nelson BP, Nalesnik MA, Bahler DW, et al. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 2000;24:375-385.
2. Leblond V, Davi F, Charlotte F, et al. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 1998;16:2052-2059.
3. Nalesnik MA. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders. Recent Results Cancer Res 2002;159:9-18.
4. Finn L, Reyes J, Bueno J, et al. Epstein-Barr virus infections in children after transplantation of the small intestine. Am J Surg Pathol 1998;22:299-309.
5. Ho M, Miller G, Atchison RW, et al. Epstein-Barr virus infections and DNA hybridization studies in post-transplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 1985;152:876-886.
6. Frizzera G. Atypical lymphoproliferative disorders. Knowles DM (ed). Neoplastic Hematopathology, 2nd ed. Lippincott Williams & Wilkins: Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo, 2001.
7. Leblond V, Sutton L, Dorent R, et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol 1995;13:961-968.
8. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988;133:173-192.
9. Penn I. The problem of cancer in organ transplant recipients: an overview. Transplant Sci 1994;4:23-32.
10. Armitage JM, Kormos RL, Stuart RS, et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 1991;10:877-86; discussion 886-887.
11. Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999;94:2208-2216.
12. Kowal-Vern A, Swinnen L, Pyle J, et al. Characterization of postcardiac transplant lymphomas. Histology, immunophenotyping, immunohistochemistry, and gene rearrangement. Arch Pathol Lab Med 1996;120:41-48.
13. Yousem SA, Randhawa P, Locker J, et al. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol 1989;20:361-369.
14. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984;1:583-587.
15. Ferry JA, Jacobson JO, Conti D, et al. Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Mod Pathol 1989;2:583-592.
16. Radl J, Valentijn RM, Haaijman JJ, et al. Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation. Clin Immunol Immunopathol 1985;37:98-102.
17. Sheil AGR, Flavel S, Disney APS, et al. Cancer in Dialysis and Transplant Patients. Transplant Proc 1985;17:195-198.
18. Penn I. Cancer and Transplantation. Marcel Dekker: New York, 1987.
19. Sheil AG, Flavel S, Disney AP, et al. Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine. Transplant Proc 1987;19:2214-2216.
20. Chucrallah AE, Crow MK, Rice LE, et al. Multiple myeloma after cardiac transplantation: an unusual form of posttransplant lymphoproliferative disorder. Hum Pathol 1994;25:541-545.
21. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995;85:552-565.
22. Swerdlow SH. Classification of the posttransplant lymphoproliferative disorders: from the past to the present. Semin Diagn Pathol 1997;14:2-7.
23. Berthelemy C, Mourad G, Bataille R, et al. Occurrence of multiple myeloma 5 years after renal transplantation. Presse Med 1988;17:1706.
24. Fischer T, Miller M, Bott-Silverman C, et al. Posttransplant lymphoproliferative disease after cardiac transplantation. Two unusual variants with predominantly plasmacytoid features. Transplantation 1996;62:1687-1690.
25. Grey M, Townsend N, Lappin D, et al. IgA myeloma of donor origin arising 7 years after allogeneic renal transplant. Br J Haematol 2000;108:592-594.
26. Ancin I, Sarra J, Peris J, et al. Demonstration of Epstein-Barr virus in a case of multiple myeloma after renal transplantation. Haematologica 2000;85:773-774.
27. Bowen PA, Caruana RJ. A secretory myeloma in a renal-transplant recipient. Clin Transplant 1991;5:408-410.
28. Leigh BR, Larkin EC, Doggett RLS. Solitary extramedullary plasmacytoma five years after successful cardiac transplantation. Am J Clin Oncol 1997;20:467-470.
29. Grogan TM, Van Camp B, Kyle RA, et al. Plasma cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Claassification of Tumours. IARC Press: Lyon, France, 2001.
30. Badley AD, Portela DF, Patel R, et al. Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder. Liver Transplant Surg 1996;2:375-382.
31. Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 1981;41:4253-4261.
32. Nelson BP, Locker J, Nalesnik MA, et al. Clonal and morphological variation in a posttransplant lymphoproliferative disorder: evolution from clonal T-cell to clonal B-cell predominance. Hum Pathol 1998;29:416-421.
33. Chadburn A, Chen JM, Hsu DT, et al. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer 1998;82:1978-1987.
34. Passweg J, Bock HA, Tichelli A, et al. Transient multiple myeloma' after intense immunosuppression in a renal transplant patient. Nephrol Dialysis Transplant 1993;8:1393-1394.
35. Howard AD, Moore J, Tomaszewski MM. Occurrence of multiple myeloma three years after successful renal transplantation. Am J Kidney Dis 1987;10:147-150.
36. Haas M, Mannhalter C, Ullrich R, et al. A multilocular B-cell neoplasia presenting as multiple myeloma and polymorphic lymphoma of recipient origin 2 months after kidney transplantation in a heart-transplant recipient. Nephrol Dialysis Transplant 1996;11:2085-2087.
37. Brown JH, Newstead CG, Jos V, et al. Multiple myeloma in a renal transplant recipient. Nephrol Dialysis Transplant 1992;7:447-449.
38. Melato M, Paladini G. Multiple myeloma following reactivated Epstein-Barr virus infection in a renaltransplant recipient. Haematologica 1986;71:241-243.
39. Aparicio M, de Precigout V, Reiffers J, et al. Multiple myeloma and AL amyloidosis in a renal transplant recipient. Nephron 1989;53:373-375.
40. Guerci AP, Burtin P, Mattei S, et al. Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases. Ann Med Interne 1992;143:155-159.